Skip to main content

Stories by Khadijah Britton

Biosimilars are back... Or are they?

As blockbuster drugs go off patent, the pharmaceutical industry is scrambling for fresh revenue sources. Follow-on versions of biologics, or "biosimilars," are being pitched as BigPharma's saving grace...

August 7, 2011 — Khadijah Britton

Biosimilars are back.... Or are they?

As blockbuster drugs go off patent, the pharmaceutical industry is scrambling for fresh revenue sources. Follow-on versions of biologics, or “biosimilars,” are being pitched as BigPharma’s saving grace...

August 7, 2011 — Khadijah Britton

The Data Are In Regarding Satoshi Kanazawa

A Hard Look at Last Week's "Objective Attractiveness" Analysis in Psychology Today If what I say is wrong (because it is illogical or lacks credible scientific evidence), then it is my problem...

May 23, 2011 — Khadijah Britton
Scroll To Top